Glaukos Corp GKOS

Healthcare Medical Devices

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. It develops novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders and retinal disease. Its product candidates include Micro-Invasive Glaucoma Surgery products that involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma and procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time. Its products include transdermal pharmaceuticals that are applied to the eyelid and designed to treat glaucoma, dry eye, presbyopia and other ocular surface diseases and disorders and micro-invasive, bio-erodible sustained release drug delivery implants to improve the vision of patients.

NYSE:GKOS - Post by User

Glaukos Corp

Bullboard Posts

Post by whytestockson May 06, 2024 4:15am

52 Views

Post# 36024359

GKOS Price Target Alert: $125.00. Issued by Jefferies

Breaking News: $GKOS GKOS Price Target Alert: $125.00. Issued by Jefferies2024-05-06 04:00:04 ET Michael Sarcone from Jefferies issued a price target of $125.00 for GKOS on 2024-05-06 01:02:00. The adjusted price target was set to $125.00. At the time of the announcement, GKOS was trading at $106.51. The overall price target consensus is at $7...GKOS - GKOS Price Target Alert: $125.00. Issued by Jefferies

Bullboard Posts

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle